The data revealed that MTCH1 expression was largely heightened in three types of carcinomas, containing liver carcinoma, pancreas carcinoma, and uterine carcinoma, but decreased in 13 types of carcinomas tissues, such as Acute Myeloid Leukemia (AML) and breast carcinoma (Figure 1). Here, MTCH1 is linked to uterine carcinoma.